• Ability to coordinate actuation and inhalation is difficult, especially as people age¹
• The majority of patients were unable to use an MDI correctly, which may have compromised treatment^1,2
• Dexterity decreases with age^3,4

With an MDI (metered dose inhaler), why can coordination and dexterity be a concern?

• Almost 1/2 of patients rate their MDI difficult to use^5,16
• Many patients lack the coordination and dexterity needed to use their MDI effectively¹

• Although the majority of MDI patients had a spacer available, only 15%
  used it⁵

Twice-daily BROVANA^® (arformoterol tartrate) may be the right fit

• No hand/breath coordination required⁶
• No deep breaths or breath holding required⁶
• Minimal dexterity required⁶

When you want them to get back into daily living, BROVANA^® (arformoterol tartrate) may be the right fit for COPD maintenance therapy

BROVANA, like other beta₂-agonists, can produce a clinically significant cardiovasuclar effect in some patients as measured by increases in pulse rate, blood pressure, and/or symptoms.